In addition, immunohistochemical staining analysis showed that the DHIE treatment group was able to downregulate the degree of Ki-67 infiltration in subcutaneous hormonal tumors and inhibit the proliferation of cancer cells in tumor tissues (Figure 11F). The gene discussed is MKI67; the disease is cancer.